Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 75923 [2013-29750]

Download as PDF Federal Register / Vol. 78, No. 240 / Friday, December 13, 2013 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–29745 Filed 12–12–13; 8:45 am] [FR Doc. 2013–29750 Filed 12–12–13; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review ehiers on DSK2VPTVN1PROD with NOTICES Prevention and the Agency for Toxic Substances and Disease Registry. Advisory Committee on Breast Cancer in Young Women (ACBCYW) The meeting announced below concerns Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monkeypox in Tshuapa District, Democratic Republic of the Congo, Funding Opportunity Announcement (FOA) CK14–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time And Date: 1:00 p.m.–3:00 p.m., February 18, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monkeypox in Tshuapa District, Democratic Republic of the Congo, FOA CK14–002’’. Contact Person For More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Mar<15>2010 13:32 Dec 12, 2013 Jkt 232001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 9:00 a.m.–3:00 p.m. EST, January 9, 2014. Place: The meeting will be held via Teleconference. Limited teleconference access is also available. Teleconference login information is as follows: For Public: TOLL–FREE PHONE #: 888–989–8135 Participant passcode: BREASTCANCER or 273278226237 For Public: Net Conference URL: https://www.my meetings.com/nc/join/ Conference number: PW3233834 Audience passcode: BREASTCANCER or Public can join the event directly at: https://www.mymeetings.com/nc/join. php?i=PW3233834&p=BREAST CANCER&t=c. There is also a toll free number for anyone outside of the USA: TOLL #: 1– 203–827–7034. Participant passcode: BREASTCANCER or 273278226237. Status: Open to the public, limited only by the net conference and audio phone lines available. Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 75923 dissemination of credible appropriate messages and resource materials. Matters To Be Discussed: The agenda will include discussions on the current and emerging topics related to breast cancer in young women. These may include risk communication and health education, as well as approaches to increase awareness of clinicians/ practitioners regarding topics such as breast cancer risk, breast health, symptoms, diagnosis, and treatment of breast cancer in young women. Agenda items are subject to change as priorities dictate. Online Registration Required: All ACBCYW Meeting participants must register for the meeting online at least 5 days in advance at https://www.cdc.gov/ cancer/breast/what_cdc_is_doing/ meetings.htm. Please complete all the required fields before submitting your registration and submit no later than January 5, 2014. Contact Person For More Information: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway NE., Mailstop K52, Atlanta, Georgia 30341, Telephone (770) 488–4518, Fax (770) 488–4760 Email: acbcyw@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–29749 Filed 12–12–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Office for State, Tribal, Local and Territorial Support (OSTLTS) In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009, and September 23, 2004, Consultation and Coordination with Indian Tribal Governments, CDC/Agency for Toxic Substances and Disease Registry (ATSDR), announces the following meeting and Tribal Consultation Session: E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 78, Number 240 (Friday, December 13, 2013)]
[Notices]
[Page 75923]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-29750]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Clinical, Epidemiologic and 
Ecologic Factors Impacting the Burden and Distribution of Monkeypox in 
Tshuapa District, Democratic Republic of the Congo, Funding Opportunity 
Announcement (FOA) CK14-002, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time And Date: 1:00 p.m.-3:00 p.m., February 18, 2014 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Clinical, Epidemiologic and Ecologic Factors Impacting the Burden 
and Distribution of Monkeypox in Tshuapa District, Democratic Republic 
of the Congo, FOA CK14-002''.
    Contact Person For More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop 
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-29750 Filed 12-12-13; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.